Andreas Wicki, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 57,552 shares at $60.13 ($3.5M) on 2022-12-13, disclosed to the SEC on 2022-12-14.
Open-market sale of $3.5M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.36 | 22,391 | $1.4M | 38.9% |
| 2 | $60.36 | 22,391 | $1.4M | 38.9% |
| 3 | $60.13 | 6,320 | $380K | 10.9% |
| 4 | $60.13 | 6,320 | $380K | 10.9% |
| 5 | $60.00 | 130 | $8K | 0.2% |
| Total | $60.31 avg | 57,552 |
| $3.5M |
| 100% |
| Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |
| HRMY | SELL | 2022-08-10 | $62.2M | — | Filing → |